New York Medical Device Lawyer

New York imposes a **three-year statute of limitations** on personal injury claims under CPLR § 214. For most medical device cases, the clock begins running from the date of injury — typically when the device failed, or when you experienced harm from the defect.

**CPLR § 214-c** provides an important exception for exposure claims: when injury results from exposure to a harmful substance (which can include degraded materials from a defective device), the three-year period runs from the date the injury was or reasonably should have been discovered. This is critical for device cases where harm — such as metallosis from metal-on-metal hip implants or mesh erosion — develops over time.

For wrongful death arising from a defective device, New York's two-year limitations period applies (EPTL § 5-4.1).

Do not assume your claim is time-barred without speaking to an attorney. Complex tolling rules, including the discovery rule and potential fraudulent concealment arguments, can affect the limitations analysis significantly.

One of the most important — and challenging — aspects of medical device litigation is federal preemption. The Medical Device Amendments of 1976 (MDA) to the Food, Drug, and Cosmetic Act create a complex preemption framework that affects which claims can be brought against device manufacturers.

**Class III devices** that went through the FDA's Premarket Approval (PMA) process receive the strongest preemption protection. PMA approval means the FDA specifically reviewed and approved the device's design and labeling. State law claims that would impose requirements "different from or in addition to" the federal requirements are preempted.

However, preemption is not absolute. The **parallel claim** doctrine allows state law claims that enforce the same standards the FDA imposed — not higher or different ones. If the manufacturer violated its own FDA-approved specifications, that parallel violation can form the basis of a claim.

**Class II devices** cleared through the 510(k) process receive less preemption protection. The Supreme Court in Riegel v. Medtronic (2008) clarified that PMA devices receive strong preemption; most 510(k) devices do not.

This analysis is product-specific and must be done carefully before asserting design defect or warning claims against a device manufacturer.

Where preemption does not bar the claim, New York applies standard product liability doctrine:

**Design defect:** New York uses a risk-utility test. A medical device is defectively designed if the risks of the design outweigh its utility and a safer alternative design was feasible. Establishing design defect in a device case typically requires a biomedical engineering expert and, often, documentation of internal design reviews.

**Manufacturing defect:** The device you received deviated from the manufacturer's approved specifications — a flaw in how that specific unit was made. Manufacturing defects may survive preemption even for Class III devices, because they assert the company failed to comply with its own FDA-approved manufacturing processes.

**Failure to warn:** The manufacturer failed to adequately disclose known risks to physicians or patients. New York recognizes the learned intermediary doctrine, which generally directs the warning duty toward surgeons and implanting physicians rather than patients directly.

New York patients have been affected by many of the nation's most significant medical device mass torts:

**Hernia mesh:** Mesh products from multiple manufacturers have faced mass tort litigation based on design defects and warning failures. New York patients with mesh complications (chronic pain, erosion, migration, infection) have active claims.

**Metal-on-metal hip implants:** Several MDL proceedings involving Stryker, DePuy, and other hip implant manufacturers include New York plaintiffs. Metallosis, pseudotumor formation, and elevated metal ion levels are common claimed injuries.

**CPAP machines:** The Philips CPAP recall involving degrading polyester-based polyurethane foam is the subject of a large MDL. New York users of affected machines may have claims.

**IVC filters:** Retrievable IVC filter fractures and migration have generated significant litigation. New York vascular surgery patients have been affected.

**Surgical staplers:** Certain models from major manufacturers have been linked to malfunctions causing anastomotic leaks, internal hemorrhage, and other serious complications.

New York does not cap compensatory damages in personal injury cases. In medical device litigation, recoverable damages typically include:

— **Revision surgery and additional medical care** — including hospitalization, anesthesia, implant removal and replacement, and ongoing wound care — **Future medical expenses** — for chronic conditions, anticipated additional procedures, and ongoing monitoring — **Lost wages and lost earning capacity** — where the device injury affected your ability to work — **Pain and suffering** — both physical pain and the psychological impact of a serious injury — **Loss of consortium** — the impact on marital or family relationships — **Out-of-pocket costs** — medical travel, adaptive equipment, home care

Punitive damages are available in New York product liability cases where the manufacturer's conduct was reckless or involved intentional concealment of known defects. In device cases, this most commonly arises where internal safety data was suppressed or where the company continued selling a device after internal reports identified failure rates.

Our evaluation of a New York medical device case involves several key steps:

1. **Device identification:** We determine the manufacturer, model, and FDA clearance/approval pathway to assess preemption risk.

2. **Preemption analysis:** We evaluate whether your theory of defect survives preemption — whether under the parallel claim doctrine or because the device was 510(k)-cleared rather than PMA-approved.

3. **Timing and limitations:** We assess when the injury occurred or was discovered and whether the claim is timely under CPLR § 214 or § 214-c.

4. **MDL status:** We determine whether the device is the subject of existing federal MDL proceedings and evaluate whether individual or consolidated filing makes sense for your case.

5. **Damages documentation:** We review medical records, employment records, and other materials to fully scope the damages picture.

If you are a New York patient who was harmed by a defective medical device, contact us for a confidential review. Federal preemption rules and complex litigation procedures make it essential to have counsel with product liability experience evaluate your case.